European Pharmacopoeia (EP) (Ph. Eur.) Solutions and Reagents

European Pharmacopoeia (EP) solutions and reagents ensure that pharmaceutical products meet the high-quality standards set by the European Union. These solutions are critical in testing the purity, potency, and quality of drugs. CymitQuimica offers a comprehensive range of Ph. Eur.-compliant solutions and reagents, supporting pharmaceutical research and quality control processes.

20
- 50
- 100
- 200

products per page. 9297 products on this category.

Product data	Purity	Price range	Estimated delivery
Picosulfate for system suitability CRS REF: 41-Y0001104CAS: 10040-45-6	- - -	115.00 €	Mon 25 Nov 24
Pramipexole dihydrochloride monohydrate CRS REF: 41-Y0001266CAS: 191217-81-9	- - -	115.00 €	Mon 25 Nov 24
Stearic acid CRS REF: 41-S1340000CAS: 57-11-4	- - -	115.00 €	Mon 25 Nov 24
Ivermectin RS REF: 41-ICRS73066CAS: 70288-86-7	- - -	102.00 €	Mon 25 Nov 24
Tropicamide for peak identification CRS REF: 41-Y0001316CAS: 1508-75-4	- - -	115.00 €	Mon 25 Nov 24
Bicalutamide for system suitability CRS REF: 41-Y0001448CAS: 90357-06-5	- - -	115.00 €	Mon 25 Nov 24
Xylometazoline impurity A CRS REF: 41-X0101000	- - -	115.00 €	Mon 25 Nov 24
Hydralazine hydrochloride CRS REF: 41-H1120000CAS: 304-20-1	- - -	115.00 €	Mon 25 Nov 24
Ampicillin (anhydrous) RS REF: 41-ICRS0211CAS: 69-53-4	- - -	102.00 €	Mon 25 Nov 24
Betamethasone sodium phosphate RS REF: 41-ICRS0229CAS: 151-73-5	- - -	102.00 €	Mon 25 Nov 24
Duloxetine for system suitability CRS REF: 41-Y0001454CAS: 136434-34-9	- - -	115.00 €	Mon 25 Nov 24
Methylprednisolone acetate for peak identification CRS REF: 41-Y0001736CAS: 53-36-1	- - -	115.00 €	Mon 25 Nov 24
Norfloxacin CRS REF: 41-N1230000CAS: 70458-96-7	- - -	115.00 €	Mon 25 Nov 24
Pefloxacin impurity C CRS REF: 41-P0309030	- - -	115.00 €	Mon 25 Nov 24
Trimethoprim impurity B CRS REF: 41-T2200010	- - -	115.00 €	Mon 25 Nov 24
Fluspirilene impurity C CRS REF: 41-Y0000375	- - -	115.00 €	Mon 25 Nov 24
Imatinib impurity H CRS REF: 41-Y0001694CAS: 350-03-8	- - -	115.00 €	Mon 25 Nov 24
Stanozolol impurity A CRS REF: 41-S1250010CAS: 521-11-9	- - -	115.00 €	Mon 25 Nov 24
Pemetrexed for system suitability CRS REF: 41-Y0001538CAS: 357166-29-1	- - -	115.00 €	Mon 25 Nov 24
Aceclofenac impurity I CRS REF: 41-Y0001915CAS: 15362-40-0	- - -	115.00 €	Mon 25 Nov 24

European Pharmacopoeia (EP) (Ph. Eur.) Solutions and Reagents

Picosulfate for system suitability CRS

Ref: 41-Y0001104

Pramipexole dihydrochloride monohydrate CRS

Ref: 41-Y0001266

Stearic acid CRS

Ref: 41-S1340000

Ivermectin RS

Ref: 41-ICRS73066

Tropicamide for peak identification CRS

Ref: 41-Y0001316

Bicalutamide for system suitability CRS

Ref: 41-Y0001448

Xylometazoline impurity A CRS

Ref: 41-X0101000

Hydralazine hydrochloride CRS

Ref: 41-H1120000

Ampicillin (anhydrous) RS

Ref: 41-ICRS0211

Betamethasone sodium phosphate RS

Ref: 41-ICRS0229

Duloxetine for system suitability CRS

Ref: 41-Y0001454

Methylprednisolone acetate for peak identification CRS

Ref: 41-Y0001736

Norfloxacin CRS

Ref: 41-N1230000

Pefloxacin impurity C CRS

Ref: 41-P0309030

Trimethoprim impurity B CRS

Ref: 41-T2200010

Fluspirilene impurity C CRS

Ref: 41-Y0000375

Imatinib impurity H CRS

Ref: 41-Y0001694

Stanozolol impurity A CRS

Ref: 41-S1250010

Pemetrexed for system suitability CRS

Ref: 41-Y0001538

Aceclofenac impurity I CRS

Ref: 41-Y0001915